Crisis hipertensivas: Actualización terapéutica
作者： Fidel Manuel Cáceres Lóriga , Horacio Pérez López
DOI:
关键词:
摘要: En los ultimos anos, se han producido adelantos en el tratamiento de las crisis hipertensivas, con cambios significativos su enfoque terapeutico. Se realiza una breve revision este tema, hincapie recomendaciones del Sixth Report Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. discute uso la nifedipina y ofrece actualizacion farmacos mas reciente utilizacion emergencias hipertensivas (esmolol, nicardipino fenoldopam).
sld.cu参考文章(46)
C. Venkata, S. Ram, Immediate Management of Severe Hypertension Cardiology Clinics. ,vol. 13, pp. 579- 591 ,(1995) , 10.1016/S0733-8651(18)30024-9
Michael M. Hirschl, Guidelines for the Drug Treatment of Hypertensive Crises Drugs. ,vol. 50, pp. 991- 1000 ,(1995) , 10.2165/00003495-199550060-00007
K.F. Bodmann, S. Tr�ster, R. Clemens, H.P. Schuster, Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis Journal of Molecular Medicine. ,vol. 72, pp. 60- 64 ,(1993) , 10.1007/BF00231120
Raymond Townsend, Brian Haggert, Charles Liss, Jonathan M Edelman, Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension Clinical Therapeutics. ,vol. 17, pp. 911- 923 ,(1995) , 10.1016/0149-2918(95)80069-7
Alan H. Gradman, Karen E. Arcuri, Allan I. Goldberg, Leila S. Ikeda, Edward B. Nelson, Duane B. Snavely, Charles S. Sweet, A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension Hypertension. ,vol. 25, pp. 1345- 1350 ,(1995) , 10.1161/01.HYP.25.6.1345
Edward A. Patmcek, Edward M. Bednarczyk, Lala M. Dunbar, Garrett E. Foulke, Terry L. Holeslaw, , Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group. Academic Emergency Medicine. ,vol. 2, pp. 959- 965 ,(1995) , 10.1111/J.1553-2712.1995.TB03122.X
Neil H. Shusterman, William J. Elliott, William B. White, Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function The American Journal of Medicine. ,vol. 95, pp. 161- 168 ,(1993) , 10.1016/0002-9343(93)90256-O
Daniel E. Everitt, Steven C. Boike, Jody R. Piltz-Seymour, Rosita VanCoevorden, Patricia Audet, Nevine Zariffa, Diane Jorkasky, Effect of Intravenous Fenoldopam on Intraocular Pressure in Ocular Hypertension The Journal of Clinical Pharmacology. ,vol. 37, pp. 312- 320 ,(1997) , 10.1002/J.1552-4604.1997.TB04308.X
Bramah N. Singh, Martin A. Josephson, Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine. American Heart Journal. ,vol. 119, pp. 427- 434 ,(1990) , 10.1016/S0002-8703(05)80063-8
Andrew Dyson, Philip A. Isaac, John H. Pennant, Adolph H. Giesecke, James M. Lipton, Esmolol attenuates cardiovascular responses to extubation. Anesthesia & Analgesia. ,vol. 71, pp. 675- 678 ,(1990) , 10.1213/00000539-199012000-00017